Inventor · disambiguated record
Adam Kois
Also filed as: KOIS ADAM
21 granted patents·3 pending applications·1,049 citations·filing 1993–2022
97Inventor score
Files withTEXAS BIOTECHNOLOGY CORP10SIGNAL PHARM LLC5IMMUNOPHARMACEUTICS INC2SIGNAL PHARM INC2ALBERS RONALD J1
Top patents by PatentIndex Score
24 records- 0197US5571821ASulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1994·Granted Nov 5, 1996·125 cites·91 claims
- 0295US7723340B2Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2006·Granted May 25, 2010·46 cites·51 claims
- 0395US5594021AThienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1995·Granted Jan 14, 1997·88 cites·174 claims
- 0495US5514691AN-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelinIMMUNOPHARMACEUTICS INC·Filed 1993·Granted May 7, 1996·128 cites·94 claims
- 0595US5464853AN-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelinIMMUNOPHARMACEUTICS INC·Filed 1993·Granted Nov 7, 1995·100 cites·25 claims
- 0694US7521446B2Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2006·Granted Apr 21, 2009·39 cites·60 claims
- 0792US5962490AThienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Oct 5, 1999·93 cites·97 claims
- 0891US6291456B1Compounds and methods for modulation of estrogen receptorsSIGNAL PHARM INC·Filed 2000·Granted Sep 18, 2001·62 cites·78 claims
- 0988US8101588B2Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewithALBERS RONALD J·Filed 2009·Granted Jan 24, 2012·22 cites·29 claims
- 1088US5977117ASubstituted phenyl compounds and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Nov 2, 1999·72 cites·73 claims
- 1188US5591761AThiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1994·Granted Jan 7, 1997·67 cites·93 claims
- 1286US7442699B2Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related theretoSIGNAL PHARM LLC·Filed 2005·Granted Oct 28, 2008·10 cites·8 claims
- 1383US7122544B2Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related theretoSIGNAL PHARM LLC·Filed 2001·Granted Oct 17, 2006·20 cites·20 claims
- 1481US6541498B2Benzenesulfonamides and the use thereof to modulate the activity of endothelinTEXAS BIOTECHNOLOGY·Filed 2000·Granted Apr 1, 2003·15 cites·43 claims
- 1580US6372739B1Compounds and methods for modulation of estrogen receptorsSIGNAL PHARM INC·Filed 2001·Granted Apr 16, 2002·13 cites·20 claims
- 1677US6030991ABenzenesulfonamides and the use thereof to modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Feb 29, 2000·47 cites·125 claims
- 1776US6265428B1Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1999·Granted Jul 24, 2001·34 cites·14 claims
- 1875US6331637B1N-Alkyl, N-Alkenyl, N-Alkynyl, N-Aryl and N-fused bicyclo or tricyclo thienyl-, furyl-,and Pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1999·Granted Dec 18, 2001·26 cites·60 claims
- 1973US6342610B2N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Jan 29, 2002·18 cites·52 claims
- 2072US6613804B2Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelinENCYSIVE PHARMACEUTICALS INC·Filed 2001·Granted Sep 2, 2003·5 cites·14 claims
- 2160US6376523B1Benzenesulfonamides and the use thereof to modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1999·Granted Apr 23, 2002·19 cites·97 claims
- 2260US2009312320A1Methods of treatment comprising the administration of haloaryl substituted aminopurines or compositions thereofSIGNAL PHARM LLC·Filed 2009·Application pending·0 cites
- 2358US2024166785A1Catechol containing polymer emulsions and methods of preparation thereofUNIV AKRON·Filed 2022·Application pending·0 cites
- 2455US2001014694A1Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelinFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Adam Kois files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →